TITLE

MEDIWOUND LAUNCHES DEBRASE GEL DRESSING PHASE IIB TRIAL

PUB. DATE
April 2003
SOURCE
Worldwide Biotech;Apr2003, Vol. 15 Issue 4, p5
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the launch of a multi-center controlled phase IIb clinical trial for the debriding agent Debrase Gel Dressing from MediWound Ltd., as of April 2003.
ACCESSION #
9427673

 

Related Articles

  • More Trouble Over EU Clinical Trials Rules. O'Donnell, Peter // Applied Clinical Trials;Jan2003, Vol. 12 Issue 1, p21 

    Focuses on the views of health practitioners on the problems associated with the implementation of the European Union directive on clinical trials. Effects of disparate legal regulations on the success of international clinical trials; Details of the protocol amendment procedures and...

  • Study Completion Times.  // Applied Clinical Trials;May2011, Vol. 20 Issue 5, p19 

    The article offers analysis on the study completion times on applied clinical trials of contract research organization or sponsor company of the study in the U.S.

  • Clinical trials: Free help for the asking!  // Hispanic Times Magazine;May/Jun1994, Vol. 15 Issue 3, p34 

    Discusses clinical trials--closely supervised investigations to evaluate new medical treatments for various maladies. How people who have received no relief for their ailment from conventional medicines may want to try a clinical trial; What they usually entail; Requirements involved; How to...

  • How to evaluate the validity and usefulness of published randomized clinical trials. Basskin, Lorne // Formulary;Mar1997, Vol. 32 Issue 3, p279 

    Presents evaluation on the validity and usefulness of published randomized clinical trials. Assessment of validity through cause-and-effect relationship; Four questions in studying usefulness. INSETS: Reasons to review randomized clinical trials (RCTs).;Shortfalls of some information...

  • Clinical drug tests: Women need not apply. Dobie, Maureen // Indianapolis Business Journal;1/22/96, Vol. 16 Issue 45, p15 

    Reports on the exclusion of women in the child-bearing age from clinical drug tests in the United States. Aim to protect eggs in womb; Preference of pharmaceutical companies for male subjects; Requiring of the intake of birth control pills for participating women.

  • Why are randomised controlled trials important? Sibbald, Bonnie; Roland, Martin // BMJ: British Medical Journal (International Edition);01/17/98, Vol. 316 Issue 7126, p201 

    Presents information on the importance of randomised controlled clinical trials. Detailed information on these trials; Details on their importance; Limitations of these trials.

  • What are pragmatic trials? Roland, Martin; Torgerson, David J. // BMJ: British Medical Journal (International Edition);01/24/98, Vol. 316 Issue 7127, p285 

    Discusses trials of healthcare interventions. What is a pragmatic trial; Difference between a pragmatic trial and a explanatory trial; Why bias is generally not seen in a pragmatic trial; Outcome measures differences between explanatory and pragmatic approaches.

  • Randomisation methods in controlled trials. Roberts, Chris; Torgerson, David // BMJ: British Medical Journal (International Edition);11/07/98, Vol. 317 Issue 7168, p1301 

    Focuses on randomization methods. Main purpose of randomization; Discussion on block and stratified randomizations; Advantages of minimization.

  • Recruiting minorities into clinical trials: Toward a... Swanson, G. Marie; Ward, Amy J. // JNCI: Journal of the National Cancer Institute;12/6/95, Vol. 87 Issue 23, p1747 

    States that the purpose of this review is to describe state of the art in recruiting participants for clinical trials designed to test methods of treatment or disease prevention. Ultimate object of review; Recruitment a problem in most clinical trials; Low participation rates in many trials;...

  • Blinding and exclusions after allocation in randomised controlled trials: Survey of published... Schulz, Kenneth F.; Grimes, David A.; al, et // BMJ: British Medical Journal (International Edition);3/23/96, Vol. 312 Issue 7033, p742 

    Reports on a study in Great Britain concerning blinding and exclusions after allocation in randomised controlled clinical trials. Survey of published group trials in obstetrics and gynecology; Objectives; Research design; Data sources; Outcome measures.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics